Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Concurrent administration of anti-PD-1 immunotherapy with one or two fractions of ultra-hypofractionated (8 Gy/fraction) radiotherapy for patients with locoregionally recurrent non-small cell lung cancer (NSCLC) after radical chemo-radiotherapy was examined in a cohort of 11 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Konstantinos, Koukourakis, Ioannis M., Anevlavis, Stavros, Giaktzidis, Axiotis, Koukourakis, Michael I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605411/
https://www.ncbi.nlm.nih.gov/pubmed/37894449
http://dx.doi.org/10.3390/cancers15205083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605411/
https://www.ncbi.nlm.nih.gov/pubmed/37894449
http://dx.doi.org/10.3390/cancers15205083

Ejemplares similares